Lamivudine Resistance and Precore Variants in Iranian Patients With Chronic Hepatitis B: Correlation With Virological and Clinical Features

Ahmad Tavakoli; Azam Khamseh; Ehsan Fakhari; Ghodratollah Montazeri; Masoud Mahmoodi Karkhaneh; Mehdi Norouzi; Reza Malekzadeh; Seyed Mohammad Jazayeri; Vahdat Poortahmasebi

首页> 外文期刊>Jundishapur Journal of Microbiology >Lamivudine Resistance and Precore Variants in Iranian Patients With Chronic Hepatitis B: Correlation With Virological and Clinical Features

【24h】

Lamivudine Resistance and Precore Variants in Iranian Patients With Chronic Hepatitis B: Correlation With Virological and Clinical Features

机译：伊朗慢性乙型肝炎患者的拉米夫定耐药性和前核变异：与病毒学和临床特征的相关性

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Jundishapur Journal of Microbiology》 |2015年第9期|共页
作者
Ahmad Tavakoli; Azam Khamseh; Ehsan Fakhari; Ghodratollah Montazeri; Masoud Mahmoodi Karkhaneh; Mehdi Norouzi; Reza Malekzadeh; Seyed Mohammad Jazayeri; Vahdat Poortahmasebi;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类微生物学;
关键词

相似文献

外文文献
中文文献
专利

1. Lamivudine resistance in patients with chronic hepatitis B: role of clinical and virological factors. [J] . Thompson AJ, Ayres A, Yuen L, Journal of gastroenterology and hepatology . 2007,第7期

机译：慢性乙型肝炎患者对拉米夫定的耐药性：临床和病毒学因素的作用。
2. Clinical and virological characteristics of lamivudine resistance in chronic hepatitis B patients: a single center experience. [J] . Sun J, Wang Z, Ma S, Journal of Medical Virology . 2005,第3期

机译：慢性乙型肝炎患者对拉米夫定耐药的临床和病毒学特征：单中心经验。
3. Adefovir and lamivudine in combination compared with adefovir monotherapy in HBeAg-negative adults with chronic hepatitis B virus infection and clinical or virologic resistance to lamivudine: A retrospective, multicenter, nonrandomized, open-label st [J] . Pellicelli AM, Barbaro G, Francavilla R, Clinical therapeutics . 2008,第2期

机译：阿德福韦和拉米夫定联合阿德福韦单药治疗慢性乙型肝炎病毒感染且对拉米夫定具有临床或病毒学耐药性的HBeAg阴性成人：回顾性，多中心，非随机，开放标签的研究
4. Adefovir dipivoxil for the treatment of chronic hepatitis B infection and in vitro evaluation of hte cross-resistance profiles of lamivudine,famciclovir and adefovir [C] . X Xiong, A Murray, H Yang, Second workshop related to HIV/AIDS in China . 1999

机译：阿德福韦酯对慢性乙型肝炎感染的治疗以及拉米夫定，泛昔洛韦和阿德福韦的交叉耐药性的体外评估
5. Intracellular drug -drug interaction between nucleoside analogs leads to early virologic failure in HIV patients receiving triple nucleoside combinations of tenofovir, lamivudine and abacavir or didanosine. [D] . Bi, Lucun. 2007

机译：核苷类似物之间的细胞内药物相互作用会导致接受替诺福韦，拉米夫定和阿巴卡韦或二羟肌苷的三核苷组合的HIV患者出现早期病毒学衰竭。
6. Lamivudine Resistance and Precore Variants in Iranian Patients With Chronic Hepatitis B: Correlation With Virological and Clinical Features [O] . Vahdat Poortahmasebi, Reza Malekzadeh, Ghodratollah Montazeri, 2015

机译：伊朗慢性乙型肝炎患者的拉米夫定耐药性和前核变异：与病毒学和临床特征的相关性
7. Lamivudine Resistance and Precore Variants in Iranian Patients With Chronic Hepatitis B: Correlation With Virological and Clinical Features [O] . Vahdat Poortahmasebi, Reza Malekzadeh, Ghodratollah Montazeri, 2015

机译：伊朗慢性乙型肝炎患者的拉米夫定抗性和预体变体：与病毒学和临床特征的相关性

Lamivudine Resistance and Precore Variants in Iranian Patients With Chronic Hepatitis B: Correlation With Virological and Clinical Features

著录项

相似文献

相关主题

期刊订阅